Risk of Serotonin Syndrome with Isoniazid
Antimicrob Agents Chemother
.
2020 Dec 16;65(1):e01455-20.
doi: 10.1128/AAC.01455-20.
Print 2020 Dec 16.
Authors
Michael E O'Brien
1
,
Ronak G Gandhi
2
,
Camille N Kotton
3
4
,
Meagan L Adamsick
2
Affiliations
1
Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts, USA Mobrien56@mgh.harvard.edu.
2
Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts, USA.
3
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
4
Harvard Medical School, Boston, Massachusetts, USA.
PMID:
33077663
PMCID:
PMC7927797
DOI:
10.1128/AAC.01455-20
No abstract available
Keywords:
isoniazid; serotonin syndrome.
Publication types
Letter
MeSH terms
Humans
Isoniazid* / adverse effects
Serotonin Syndrome* / chemically induced
Substances
Isoniazid